SPL 0.54% 9.4¢ starpharma holdings limited

Breaking: VivaGel sales guidance

  1. 3,419 Posts.
    lightbulb Created with Sketch. 811
    Alan Kohler: What sort of revenue is Starpharma expecting from VivaGel sales?

    CEO Jackie: ”We haven’t provided at this stage a detailed guidance in terms of the revenue numbers, as I guess we launch in more markets and as we actually have the product on the market in more markets, we will be providing guidance”

    *This interview is publicly available on YouTube.

    **Unfortunately for shareholders this interview was in mid 2019.

    *** That was probably a fair statement by the CEO at the time. But it’s NOW loooong overdue. Seriously, three and a half years later Starpharma will still not provide any guidance on VivaGel BV sales.

    In my personal opinion, this is because the CEO is EMBARRASSED.
    Last edited by sarge17: 26/09/22
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(0.54%)
Mkt cap ! $38.81M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $64 682

Buyers (Bids)

No. Vol. Price($)
2 394540 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 57000 3
View Market Depth
Last trade - 11.26am 13/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.